AbbVie
ABBV
1,297 hedge funds and large institutions have $49B invested in AbbVie in 2013 Q3 according to their latest regulatory filings, with 77 funds opening new positions, 477 increasing their positions, 562 reducing their positions, and 53 closing their positions.
166% more call options, than puts
Call options by funds: $297M | Put options by funds: $111M
45% more first-time investments, than exits
New positions opened: 77 | Existing positions closed: 53
10% more capital invested
Capital invested by funds: $44.6B → $49B (+$4.47B)
8% more funds holding in top 10
Funds holding in top 10: 39 → 42 (+3)
0.88% more ownership
Funds ownership: 68.14% → 69.02% (+0.88%)
1% more funds holding
Funds holding: 1,286 → 1,297 (+11)
15% less repeat investments, than reductions
Existing positions increased: 477 | Existing positions reduced: 562
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$136M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$118M |
| 3 |
Bank of New York Mellon
New York
|
+$112M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$104M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$125M |
| 2 |
PC
PointState Capital
New York
|
-$70.9M |
| 3 |
EIP
Epoch Investment Partners
New York
|
-$67M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$60.6M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$51.4M |
ABBV Hedge Fund Activity: Q3 2013 in Review
1,297 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q3 2013, worth a combined $49B — up 10% from $44.6B a quarter earlier.
Buyers outnumbered sellers: 77 funds opened new ABBV positions and 53 closed out — a net gain of 24 holders — while 477 added to existing stakes and 562 trimmed.
The largest buyer was Vanguard Group, adding an estimated $136M. The largest seller was Capital Research Global Investors, cutting an estimated $125M.
- 1,297 institutional investors held AbbVie (ABBV) as of Q3 2013, up from 1,286 in Q2 2013.
- Funds reported $49B of AbbVie stock for Q3 2013, up 10% quarter-over-quarter.
- 77 funds opened new AbbVie positions in Q3 2013 and 53 closed out, a net change of +24 holders.
- The largest AbbVie buyer in Q3 2013 was Vanguard Group, an estimated $136M added.
- The largest AbbVie seller in Q3 2013 was Capital Research Global Investors, an estimated $125M sold.
Based on aggregated 13F filings for Q3 2013.